Law360, New York (June 18, 2012, 12:29 PM ET) -- The U.S. Supreme Court ruled Monday that a proposed class of GlaxoSmithKline PLC sales representatives are outside employees exempt from federal overtime pay requirements, rejecting the U.S. Department of Labor's position and handing a major victory to the pharmaceutical industry.
In a 5-4 decision, the high court found that drug representatives — who are legally prohibited from closing sales — are outside sales workers and are therefore exempt from the Fair Labor Standards Acts overtime requirements. The justices ruled that the DOL's stance that the pharmaceutical...
High Court Deems GSK Drug Sales Reps OT-Exempt
To view the full article, take a free trial now.
